 Monoamine oxidase B inhibitors are still receiving great attention as promising therapeutic agents for central nervous system disorders . This study explores for the first time the potential of 3 thiophenylcoumarins as

@highlight 3 Thiophenylcoumarins as
@highlight and
@highlight agents against Parkinsons disease.
@highlight MAO A and MAO B inhibition DPPH scavenging and inhibition of ROS formation.
@highlight Neurotoxicity on motor cortex neurons and neuroprotection against H
@highlight OFT for the best candidate a reversible MAO B inhibitor IC
@highlight  140nM .
@highlight Compound
@highlight is better
@highlight than selegiline in reserpinized mice LD B treatment .
